-
Survey: Employee wellness programs biggest driver toward reducing cost of health care
MENLO PARK, Calif. — Employee wellness programs have become a popular strategy for employers trying to control costs, according to the Kaiser Family Foundation/Health Research and Educational Trust 2013 Employer Health Benefits Survey released Tuesday.
-
FDA approves Mylan antidepressant after company reaffirms efficacy
PITTSBURGH — The Food and Drug Administration has approved a supplemental regulatory application from Mylan for a generic antidepressant that was subject last year to scrutiny by the agency amid reports of efficacy problems, Mylan said Thursday.
The drug maker announced the approval of its supplemental abbreviated new drug application, or sANDA, for bupropion hydrochloride extended-release tablets in the 300-mg strength. The drug is a generic version of GlaxoSmithKline's Wellbutrin XL.